CompanyGraph
What stands out
- Earnings significantly exceed cash generation
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleLevered free cash flow is $64.98M, above the global median of $16.24M
- FinancialsAltman Z-Score 3.36: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
5.40%Above 5Y avg (3.05%)
Annual Rate
TWD 1.75Paid annual
Payout Ratio
179.6%High
Payback Period
18.9 yr
Last Ex-Dividend
Aug 17, 2026
The reported statements, read against the company's own industry.
What stands out
- Earnings significantly exceed cash generation
Financials view
Market Capitalization
25.59BTWD803.05M · vs all stocks (USD)
Trailing P/E
79.88xRevenue (TTM)
1.66BTWD51.99M · vs all stocks (USD)
Profit Margin
61.51%52-Week Change
-4.94%vs all stocks
Market Capitalization
25.59BTWD803.05M · vs all stocks (USD)
Enterprise Value
24.43BTWD766.64M · vs all stocks (USD)
Trailing P/E
79.88xPEG Ratio
0.3046xPrice to Sales (TTM)
15.26xPrice to Book (MRQ)
1.41xEnterprise to Revenue
14.75xEnterprise to EBITDA
109.66xGross Margin
46.58%Profit Margin
61.51%Return on Assets (TTM)
0.15%Return on Equity (TTM)
6.00%Revenue (TTM)
1.66BTWD51.99M · vs all stocks (USD)
Revenue per Share (TTM)
2.22TWDUpdated Aug 20, 2026Quarterly Revenue Growth
14.10%Gross Profit (TTM)
716.93MTWD22.50M · vs all stocks (USD)
EBITDA (TTM)
222.76MTWD6.99M · vs all stocks (USD)
Net Income (TTM)
1.02BTWD31.98M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
22.99%Operating Cash Flow (TTM)
283.16MTWD8.89M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
2.07BTWD64.98M · vs all stocks (USD)
Trailing Annual Dividend Rate
1.75TWDUpdated Aug 20, 2026Trailing Annual Dividend Yield
5.40%vs all stocks
5-Year Average Dividend Yield
3.05%vs all stocks
Payout Ratio
179.58%Minority Interest (Equity)
6.00KTWDFY2025 · Dec 31, 2025Revenue
1.52BTWDFY2025 · Dec 31, 2025Cost of Goods Sold
894.93MTWDFY2025 · Dec 31, 2025Gross Profit
621.26MTWDFY2025 · Dec 31, 2025Operating Income
-362.08MTWD-11.36M · vs all stocks (USD)
Pre-tax Income
11.57BTWDFY2025 · Dec 31, 2025Income Tax Expense
2.25BTWDFY2025 · Dec 31, 2025Net Income
9.32BTWDFY2025 · Dec 31, 2025EBIT
11.77BTWDFY2025 · Dec 31, 2025EBITDA (Income Statement)
-265.57MTWDFY2025 · Dec 31, 2025Research & Development
84.78MTWDFY2025 · Dec 31, 2025Selling, General & Administrative
449.67MTWDFY2025 · Dec 31, 2025Other Operating Expenses
448.88MTWDFY2025 · Dec 31, 2025Non-operating Interest Income
31.66MTWDFY2025 · Dec 31, 2025Non-operating Interest Expense
204.36MTWDFY2025 · Dec 31, 2025Minority Interests (P&L)
0.00TWDFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00TWDFY2025 · Dec 31, 2025Operating Cash Flow
11.68BTWDFY2025 · Dec 31, 2025Free Cash Flow
11.48BTWDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
237.56MTWDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
11.57BTWDFY2025 · Dec 31, 2025Stock-based Compensation
7.15MTWDFY2025 · Dec 31, 2025Other Non-cash Items
175.42MTWDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-31.14MTWDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-39.50MTWDFY2025 · Dec 31, 2025Capital Expenditures
-205.50MTWDFY2025 · Dec 31, 2025Net Intangibles (CF)
-2.71MTWDFY2025 · Dec 31, 2025Net Acquisitions
328.80MTWDFY2025 · Dec 31, 2025Purchase of Investments
-75.37MTWDFY2025 · Dec 31, 2025Sale of Investments
1.45BTWDFY2025 · Dec 31, 2025Other Investing Activity
-2.65MTWDFY2025 · Dec 31, 2025Net Investing Cash Flow
1.50BTWDFY2025 · Dec 31, 2025Long-term Debt Issuance
250.90MTWDFY2025 · Dec 31, 2025Long-term Debt Payments
-2.20BTWDFY2025 · Dec 31, 2025Net Short-term Debt Issuance
-212.00MTWDFY2025 · Dec 31, 2025Common Stock Repurchase
-383.08MTWDFY2025 · Dec 31, 2025Common Dividends Paid
-540.27MTWDFY2025 · Dec 31, 2025Other Financing Charges
-2.13MTWDFY2025 · Dec 31, 2025Net Financing Cash Flow
-3.09BTWDFY2025 · Dec 31, 2025Shares Outstanding
746.53MSharesUpdated Aug 20, 2026Float Shares
564.72MSharesUpdated Aug 20, 2026% Held by Insiders
25.47%vs all stocks
% Held by Institutions
7.43%vs all stocks
Total Cash (MRQ)
3.61BTWD113.17M · vs all stocks (USD)
Total Cash per Share (MRQ)
4.76TWDUpdated Aug 20, 2026Total Debt (MRQ)
3.89BTWD122.06M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.2267xCurrent Ratio (MRQ)
1.85xBook Value per Share (MRQ)
22.63TWDUpdated Aug 20, 2026Total Assets
34.63BTWD1.09B · vs all stocks (USD)
Total Current Assets
1.59BTWDFY2025 · Dec 31, 2025Total Liabilities
8.14BTWDFY2025 · Dec 31, 2025Total Non-current Assets
33.04BTWDFY2025 · Dec 31, 2025Total Non-current Liabilities
4.63BTWDFY2025 · Dec 31, 2025Total Current Liabilities
3.51BTWDFY2025 · Dec 31, 2025Cash & Cash Equivalents
237.56MTWDFY2025 · Dec 31, 2025Other Short-term Investments
736.64MTWDFY2025 · Dec 31, 2025Accounts Receivable
214.17MTWDFY2025 · Dec 31, 2025Inventory
353.48MTWDFY2025 · Dec 31, 2025Accounts Payable
119.32MTWDFY2025 · Dec 31, 2025Short-term Debt
2.93BTWDFY2025 · Dec 31, 2025Other Current Liabilities
20.43MTWDFY2025 · Dec 31, 2025Long-term Debt
1.77BTWDFY2025 · Dec 31, 2025Other Non-current Liabilities
906.00KTWDFY2025 · Dec 31, 2025Common Stock (Book)
7.61BTWDFY2025 · Dec 31, 2025Retained Earnings
9.33BTWDFY2025 · Dec 31, 2025Total Shareholders' Equity
26.49BTWD831.21M · vs all stocks (USD)
Treasury Stock
592.73MTWDFY2025 · Dec 31, 202552-Week Low
31.53TWDUpdated Aug 20, 202652-Week High
48.96TWDUpdated Aug 20, 202652-Week Change
-4.94%vs all stocks
50-Day MA
36.05TWDUpdated Aug 20, 2026200-Day MA
37.54TWDUpdated Aug 20, 2026Avg 10-Day Volume
3.79MSharesUpdated Aug 20, 2026Avg 30-Day Volume
2.41MSharesUpdated Aug 20, 2026Diluted EPS (TTM)
0.4000TWDUpdated Aug 20, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Earnings significantly exceed cash generationSignificant
Net Income (USD, TTM): 31,978,822.374Operating Cash Flow (USD, TTM): 8,886,032.723
Financial Health
Altman Z-Score 3.36: safe zoneNotable
Altman Z-Score: 3.36
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Levered free cash flow is $64.98M, above the global median of $16.24MNotable
Levered free cash flow (USD): 64,983,596.138Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Zhejiang Anglikang Pharmaceuticals Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shanxi Zhendong Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Jacobio Pharmaceuticals Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Shenzhen YHLO Biotech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Beijing Konruns Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Hangzhou Bio-Sincerity Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Chengda Pharmaceuticals Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Bioventus Inc.
Tier 1ProductionApproval-Gated PipelineRule
CytomX Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Esperion Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule